Biotechnological Trends in Spider and Scorpion Antivenom Development
AbstractSpiders and scorpions are notorious for their fearful dispositions and their ability to inject venom into prey and predators, causing symptoms such as necrosis, paralysis, and excruciating pain. Information on venom composition and the toxins present in these species is growing due to an interest in using bioactive toxins from spiders and scorpions for drug discovery purposes and for solving crystal structures of membrane-embedded receptors. Additionally, the identification and isolation of a myriad of spider and scorpion toxins has allowed research within next generation antivenoms to progress at an increasingly faster pace. In this review, the current knowledge of spider and scorpion venoms is presented, followed by a discussion of all published biotechnological efforts within development of spider and scorpion antitoxins based on small molecules, antibodies and fragments thereof, and next generation immunization strategies. The increasing number of discovery and development efforts within this field may point towards an upcoming transition from serum-based antivenoms towards therapeutic solutions based on modern biotechnology. View Full-Text
Share & Cite This Article
Laustsen, A.H.; Solà, M.; Jappe, E.C.; Oscoz, S.; Lauridsen, L.P.; Engmark, M. Biotechnological Trends in Spider and Scorpion Antivenom Development. Toxins 2016, 8, 226.
Laustsen AH, Solà M, Jappe EC, Oscoz S, Lauridsen LP, Engmark M. Biotechnological Trends in Spider and Scorpion Antivenom Development. Toxins. 2016; 8(8):226.Chicago/Turabian Style
Laustsen, Andreas H.; Solà, Mireia; Jappe, Emma C.; Oscoz, Saioa; Lauridsen, Line P.; Engmark, Mikael. 2016. "Biotechnological Trends in Spider and Scorpion Antivenom Development." Toxins 8, no. 8: 226.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.